XML 66 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 6 Months Ended
Nov. 25, 2012
Nov. 27, 2011
Consolidated net income $ 13,435,000 $ 5,391,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 3,661,000 2,729,000
Stock-based compensation expense 671,000 885,000
Tax benefit from stock-based compensation expense (1,814,000) (3,378,000)
Increase in long-term receivable   (400,000)
Loss on disposal of property and equipment 180,000  
Deferred taxes 3,039,000 (463,000)
Change in contingent consideration (3,933,000)  
Change in investment in non-public company (fair market value) (5,252,000) (1,174,000)
Changes in current assets and current liabilities:    
Accounts receivable, net (8,644,000) (7,407,000)
Accounts receivable, related party 10,000 139,000
Income taxes receivable 1,840,000 3,554,000
Inventories, net (2,391,000) (14,000)
Issuance of notes and advances receivable   (1,586,000)
Collection of notes and advances receivable   240,000
Prepaid expenses and other current assets (436,000) 652,000
Accounts payable 3,300,000 2,140,000
Related party accounts payable (351,000) 32,000
Accrued compensation (1,223,000) 304,000
Other accrued liabilities (616,000) (84,000)
Deferred revenue 908,000 (2,302,000)
Net cash provided by (used in) operating activities 2,384,000 (742,000)
Purchases of property and equipment (3,280,000) (3,042,000)
Purchase of marketable securities (2,459,000) (19,066,000)
Proceeds from maturities and sale of marketable securities   6,800,000
Net cash (used in) provided by investing activities (5,239,000) 846,000
Repurchase of outstanding common stock   (4,805,000)
Proceeds from sale of common stock 651,000 91,000
Taxes paid by Company for stock swaps and RSUs (49,000) (24,000)
Tax benefit from stock-based compensation expense 1,814,000 3,378,000
Earn out payment from Lifecore acquisition (9,650,000)  
Payments on long-term debt (3,090,000) (2,330,000)
Payments on lines of credit (4,166,000)  
(Increase) decrease in other assets 344,000 (57,000)
Payments to minority interest holders (320,000) (257,000)
Net cash used in financing activities (14,466,000) (4,004,000)
Net decrease in cash and cash equivalents (17,321,000) (3,900,000)
Cash and cash equivalents at beginning of period 22,177,000 8,135,000
Cash and cash equivalents at end of period 4,856,000 4,235,000
Long-term receivable   400,000
Unrealized gain from interest rate swap   32,000
Earnout [Member]
    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Change in contingent consideration (3,933,000)  
Change In Value [Member]
    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Change in contingent consideration 3,933,000  
Marketable Maturities [Member]
    
Changes in current assets and current liabilities:    
Proceeds from maturities and sale of marketable securities 500,000 16,136,000
Marketable Sales [Member]
    
Changes in current assets and current liabilities:    
Proceeds from maturities and sale of marketable securities   $ 6,818,000